AVROBIO Performance
| AVRODelisted Stock | USD 1.40 0.04 2.78% |
The firm shows a Beta (market volatility) of -0.29, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning AVROBIO are expected to decrease at a much lower rate. During the bear market, AVROBIO is likely to outperform the market. AVROBIO currently shows a risk of 0.0%. Please confirm AVROBIO expected short fall, and the relationship between the maximum drawdown and rate of daily change , to decide if AVROBIO will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days AVROBIO has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, AVROBIO is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 92.8 M |
AVROBIO |
AVROBIO Relative Risk vs. Return Landscape
If you would invest 140.00 in AVROBIO on August 28, 2024 and sell it today you would earn a total of 0.00 from holding AVROBIO or generate 0.0% return on investment over 90 days. AVROBIO is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than AVROBIO, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AVROBIO Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AVROBIO's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as AVROBIO, and traders can use it to determine the average amount a AVROBIO's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AVRO |
Based on monthly moving average AVROBIO is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AVROBIO by adding AVROBIO to a well-diversified portfolio.
AVROBIO Fundamentals Growth
AVROBIO Stock prices reflect investors' perceptions of the future prospects and financial health of AVROBIO, and AVROBIO fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AVROBIO Stock performance.
| Return On Equity | 0.43 | |||
| Return On Asset | -0.35 | |||
| Current Valuation | (26.51 M) | |||
| Shares Outstanding | 44.89 M | |||
| Price To Earning | (4.11) X | |||
| Price To Book | 0.60 X | |||
| EBITDA | (71.05 M) | |||
| Cash And Equivalents | 132.41 M | |||
| Cash Per Share | 3.03 X | |||
| Total Debt | 878 K | |||
| Debt To Equity | 0.13 % | |||
| Book Value Per Share | 1.98 X | |||
| Cash Flow From Operations | (63.19 M) | |||
| Earnings Per Share | 0.69 X | |||
| Total Asset | 101.09 M | |||
| Retained Earnings | (477.27 M) | |||
| Current Asset | 30.6 M | |||
| Current Liabilities | 3.26 M | |||
About AVROBIO Performance
By examining AVROBIO's fundamental ratios, stakeholders can obtain critical insights into AVROBIO's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that AVROBIO is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.Things to note about AVROBIO performance evaluation
Checking the ongoing alerts about AVROBIO for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for AVROBIO help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AVROBIO is now traded under the symbol TECX. Please update your portfolios or report it if you believe this is an error. Report It! | |
| AVROBIO is not yet fully synchronised with the market data | |
| AVROBIO may become a speculative penny stock | |
| AVROBIO has a very high chance of going through financial distress in the upcoming years | |
| AVROBIO currently holds about 132.41 M in cash with (63.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 69.0% of the company shares are held by institutions such as insurance companies |
- Analyzing AVROBIO's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AVROBIO's stock is overvalued or undervalued compared to its peers.
- Examining AVROBIO's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AVROBIO's management team can have a significant impact on its success or failure. Reviewing the track record and experience of AVROBIO's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of AVROBIO's stock. These opinions can provide insight into AVROBIO's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in AVROBIO Stock
If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |